ArticleJournal of cancer research and clinical oncology2012

Pharmacologic inhibition of mTOR antagonizes the cytotoxic activity of pemetrexed in non-small cell lung cancer.

Boyka Markova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.